Placemark Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Placemark Investments’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$5.18M	Sell	12,633 -1,054	-8%	-$414K	0.09%	274
2014 Q3	$4.93M	Buy	13,687 +2,414	+21%	+$809K	0.09%	272
2014 Q2	$3.19M	Buy	11,273 +92	+0.8%	+$27.3K	0.06%	403
2014 Q1	$3.36M	Buy	11,181 +1,148	+11%	+$354K	0.06%	360
2013 Q4	$2.76M	Sell	10,033 -502	-5%	-$144K	0.05%	456
2013 Q3	$3.3M	Buy	10,535 +988	+10%	+$260K	0.06%	363
2013 Q2	$2.15M	Buy	+9,547	New	+$2.22M	0.05%	470

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Placemark Investments's REGN Position: Q4 2014 in Review

Placemark Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 7.7% in Q4 2014, selling an estimated $414K and leaving 12,633 shares worth $5.18M. The position accounts for 0.09% of the portfolio, ranked #274.

Placemark Investments first reported a position in REGN in Q2 2013 and has held it in 7 quarters since. 512 funds tracked by Wall St. Rank hold REGN as of Q4 2014.

Placemark Investments held 12,633 shares of Regeneron Pharmaceuticals worth $5.18M as of Q4 2014.
Placemark Investments sold 1,054 Regeneron Pharmaceuticals shares in Q4 2014, an estimated $414K.
Regeneron Pharmaceuticals made up 0.09% of Placemark Investments's portfolio in Q4 2014, its #274 holding.
Placemark Investments first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
512 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.